Authors: RIEDL CR HUEBNER WA MOSSIG H OGRIS E PFLUEGER H

Citation: Cr. Riedl et al., PROGNOSTIC VALUE OF PROSTATE-SPECIFIC ANTIGEN MINIMUM AFTER ORCHIECTOMY IN PATIENTS WITH STAGE-C AND STAGE-D PROSTATIC-CARCINOMA, British Journal of Urology, 76(1), 1995, pp. 34-40

Authors: STONER E ANDRIOLE GL BOAKE R BRACKEN BR BRANNAN W FUSELIER H BREMNER W BRUSKEWITZ RC COX CE PATTERSON AL CUNNINGHAM GR DEVINE PC SCHELLHAMMER PF ELHILALI M GELLER J GRAYHACK JT HARRISON LH HUDSON PB IMPERATO J VAUGHAN ED LIEBER MM LIPPERT MC MALEK GH MCCONNELL JD NARAYAN P PERREAULT JP RESNICK MI NORMAN R RITTMASTER R ROMAS NA ROSNER W ROSENBLATT S ROY JB SEIDMON EJ TENOVER JS TRACHTENBERG J WILLIAMS RD WALSH PC MOCELLINI A GARDINER R MARSHALL V JOHNSON W BARTSCH G SCHMIDBAUER CP MOSSIG H GASSER G VANCANGH PJ DENIS LJ ARAP S FREIRE GC DELATORRE D BOTTO H RICHARD F DEVONEC M TEILLAC P VALLANCIEN G BRAF Z DISILVERIO F MIANO L PAGANO F GABILONDO F DEBRUYNE F JANKNEGT RA SCHROEDER FH ROLLEMA HJ NACEY J FURTADO LA CARRETERO P JIMENEZ FC HAURI D OTTO R OTTO U ALBRECHT J ALTWEIN JE EGGHART G ENGELMANN U JACOBI GH KREYES G PANIJEL M RIEDASCH G RUGENDORFF EW WEIZERT P FABRICIUS P OBOYLE PJ GINGELL C HEAL MR CHARIG C

Citation: E. Stoner et al., 3-YEAR SAFETY AND EFFICACY DATA ON THE USE OF FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, Urology, 43(3), 1994, pp. 284-294